Monitor for further 8-K filings updating the scope of the incident and any material financial impact. The disruption to order processing and shipping creates near-term revenue recognition risk; watch for customer order cancellations or delays in the next quarterly report.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Aug 26 $48.17entry
- T+1 · 3mo ago −3.11%α −3.77% · $46.67
- T+5 · 3mo ago +0.42%α +0.54% · $48.37
- T+20 · 8w ago −9.24%α −10.44% · $43.72
- T+57 · todayOpen
- T+60 · in 2d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Boston Scientific disclosed a cybersecurity incident on August 25, 2026, that has caused a global disruption to its operations, including the ability to process and ship customer orders. The company has activated its incident response protocols and is investigating with third-party experts, but the full scope, nature, and financial impact are not yet known. This is a material operational disruption for a $72.3B medical device company, creating near-term uncertainty around revenue recognition and order fulfillment.
Key Facts
- Cybersecurity incident detected on August 25, 2026, causing global operational disruption.
- Disruption includes inability to process and ship customer orders.
- Incident response protocols activated with third-party cybersecurity experts.
- Full scope, nature, and financial/operational impacts not yet determined.
- Timeline for full restoration of systems is not yet known.
Financial Impact
Operational disruption affecting order processing and shipping; financial impact not yet quantified by the company.
Risk Factors
- Prolonged systems outage could materially impact near-term revenue and customer relationships.
- Potential for data breach-related litigation, regulatory fines, and reputational damage.
- Uncertainty around the timeline for full restoration of operations.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000885725-26-000056 |
| Document: 0000885725-26-000056-index.html | 0000885725-26-000056 |
| Document: 0000885725-26-000056.txt | 0000885725-26-000056 |
Track record
22 reports on BSX
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +8.25% at T+20 after the Jul 27, 2026 report. 6 of 8 went positive at some point.
Filters
- Oct 28, 202619d ago 8-K Bearish 6/10 No price data
- Oct 28, 202619d ago Press Release Bearish 5/10 Entry $42.43 Now $43.69 −2.97% settles Nov 25
- Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $45.69 Now $43.69 +4.38% settles Nov 20
- Oct 7, 20265w ago 8-K Mixed 6/10 Entry $41.58 to $45.82 Now $43.69 +5.07% ▲ +10.20% +11.54% vs SPY
- Sep 23, 20267w ago 8-K Bearish 5/10 Entry $44.62 to $44.51 Now $43.69 +2.08% ▲ +0.25% +0.93% vs SPY
- Aug 31, 202611w ago Court Ruling Neutral 2/10 Entry $48.08 to $43.65 Now $43.69 −9.13% ▼ −9.21% −9.57% vs SPY
- Aug 26, 202611w ago 8-K Bearish 6/10 Viewing Entry $48.17 to $43.72 Now $43.69 +9.30% ▲ +9.24% +10.44% vs SPY
- Aug 22, 202612w ago Institutional Cluster Mixed 6/10 Entry $49.01 to $44.92 Now $43.69 −10.85% ▼ −8.35% −9.66% vs SPY
- Aug 7, 202614w ago Insider Cluster Mixed 6/10 Entry $50.46 to $44.98 Now $43.69 −13.42% ▼ −10.86% −9.95% vs SPY
- Aug 7, 202614w ago Insider Cluster Mixed 5/10 Entry $50.46 to $44.98 Now $43.69 −13.42% ▼ −10.86% −9.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers